These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A device for the restraint of Dilantin hypertrophy. Levene BF; Lubatta LA J Prosthet Dent; 1975 Mar; 33(3):313-4. PubMed ID: 1089786 [No Abstract] [Full Text] [Related]
4. Use of CO2 laser for gingivectomy in a patient with Sturge-Weber disease complicated by dilantin hyperplasia. Hylton RP J Oral Maxillofac Surg; 1986 Aug; 44(8):646-8. PubMed ID: 2942651 [No Abstract] [Full Text] [Related]
8. Gingival hypertrophy due to drugs. Lowenthal A; Lowenthal MN Isr Med Assoc J; 2001 Sep; 3(9):705. PubMed ID: 11574994 [No Abstract] [Full Text] [Related]
9. [Gingival hypertrophy induced by sodium diphenylhidantoinate. Some histochemical observations on the distribution of the protein fractions]. Branchini C Minerva Stomatol; 1967 Aug; 16(8):515-8. PubMed ID: 5235447 [No Abstract] [Full Text] [Related]
10. Case of the month. Gingival enlargement. Bhatt AP J Indian Dent Assoc; 1983 Aug; 55(8):inside front cover. PubMed ID: 6582162 [No Abstract] [Full Text] [Related]
17. Dermatology mediquiz. Case 5. Bluefarb SM Med Times; 1975 Mar; 103(3):45-51. PubMed ID: 1113634 [No Abstract] [Full Text] [Related]
18. [Contribution to the pathogenesis of gingival hypertrophy due to diphenylhydantoin in experiments on animals]. Giannì E; Bracchetti A Minerva Stomatol; 1968 Jun; 17(6):609-12. PubMed ID: 5244208 [No Abstract] [Full Text] [Related]
19. Sturge-Weber syndrome: deep venous occlusion and the radiologic spectrum. Slasky SE; Shinnar S; Bello JA Pediatr Neurol; 2006 Nov; 35(5):343-7. PubMed ID: 17074605 [TBL] [Abstract][Full Text] [Related]
20. [Changes in the mouth mucosa in Sturge-Weber syndrome]. Wannenmacher MF; Forck G Dtsch Zahnarztl Z; 1970 Oct; 25(10):1030-5. PubMed ID: 5274298 [No Abstract] [Full Text] [Related] [Next] [New Search]